Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus

被引:260
作者
vanderBurgh, A
Dees, J
Hop, WCJ
vanBlankenstein, M
机构
[1] UNIV ROTTERDAM HOSP,DEPT INTERNAL MED 2,DIV GASTROENTEROL,NL-3015 GD ROTTERDAM,NETHERLANDS
[2] ERASMUS UNIV ROTTERDAM,INST EPIDEMIOL & BIOSTAT,ROTTERDAM,NETHERLANDS
关键词
oesophageal cancer; Barrett's oesophagus;
D O I
10.1136/gut.39.1.5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background-Barrett's oesophagus carries a 30-fold to 40-fold increased risk of oesophageal cancer. It is unknown whether endoscopic surveillance programmes reduce mortality from oesophageal cancer. Methods-A cohort study was undertaken of all 166 patients in whom the diagnosis Barrett's oesophagus had been established between 1973 and 1986. Results-One hundred and fifty five of 166 patients could be traced (93%). During a mean follow up of 9.3 years (amounting to 1440 patient years) eight patients had developed oesophageal cancer at random intervals (one case in 180 patient years). All but one of the tumours were diagnosed at endoscopy for symptoms, three in the stage of carcinoma in situ. Risk factors for the development of oesophageal cancer were extensive Barrett's oesophagus exceeding 10 cm (p=0.02) and Barrett's ulcer at the time of intake (p=0.009). Seventy six patients were alive; three had undergone surgery for oesophageal cancer and were without recurrence respectively, 12.8 years, 12.1 years, and 7 months postoperatively. Seventy nine patients had died; five of them had developed oesophageal cancer, but in only two cases this had been the cause of death (2.5%). Conclusions-Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. The patients of this cohort would not have benefited from an endoscopic surveillance programme.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 19 条
  • [1] ACHKAR E, 1988, AM J GASTROENTEROL, V83, P291
  • [2] THE INCIDENCE OF ADENOCARCINOMA IN COLUMNAR-LINED (BARRETTS) ESOPHAGUS
    CAMERON, AJ
    OTT, BJ
    PAYNE, WS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (14) : 857 - 859
  • [3] CAMERON AJ, 1990, GASTROENTEROLOGY, V99, P818
  • [4] CAMERON AJ, 1993, OESOPHAGEAL MUCOSA 3, P10
  • [5] BARRETTS ESOPHAGUS - DEVELOPMENT OF DYSPLASIA AND ADENOCARCINOMA
    HAMEETEMAN, W
    TYTGAT, GNJ
    HOUTHOFF, HJ
    VANDENTWEEL, JG
    [J]. GASTROENTEROLOGY, 1989, 96 (05) : 1249 - 1256
  • [6] LENGTH OF BARRETT-ESOPHAGUS - AN IMPORTANT FACTOR IN THE DEVELOPMENT OF DYSPLASIA AND ADENOCARCINOMA
    IFTIKHAR, SY
    JAMES, PD
    STEELE, RJC
    HARDCASTLE, JD
    ATKINSON, M
    [J]. GUT, 1992, 33 (09) : 1155 - 1158
  • [7] KRISHNADATH KK, 1994, EUR J GASTROEN HEPAT, V7, P81
  • [8] KRISHNADATH KK, 1995, J PATHOL, V175, P1
  • [9] MENCKEPLUYMERS MBE, 1993, CANCER, V72, P1155
  • [10] ONLY PATIENTS WITH DYSPLASIA PROGRESS TO ADENOCARCINOMA IN BARRETT-ESOPHAGUS
    MIROS, M
    KERLIN, P
    WALKER, N
    [J]. GUT, 1991, 32 (12) : 1441 - 1446